Author:
Mir Rashid,Elfaki Imadeldin,Waza Ajaz Ahmad,AbuDuhier Faisel M.
Reference75 articles.
1. Gorecka J, Kostiuk V, Fereydooni A, Gonzalez L, Luo J, Dash B, Isaji T, Ono S, Liu S, Lee SR et al (2019) The potential and limitations of induced pluripotent stem cells to achieve wound healing. Stem Cell Res Ther 10(1):87
2. Kashpur O, Smith A, Gerami-Naini B, Maione AG, Calabrese R, Tellechea A, Theocharidis G, Liang L, Pastar I, Tomic-Canic M et al (2019) Differentiation of diabetic foot ulcer-derived induced pluripotent stem cells reveals distinct cellular and tissue phenotypes. FASEB J 33(1):1262–1277
3. van Wilgenburg B, Browne C, Vowles J, Cowley SA (2013) Efficient, long term production of monocyte-derived macrophages from human pluripotent stem cells under partly-defined and fully-defined conditions. PLoS One 8(8):e71098
4. Petrova A, Celli A, Jacquet L, Dafou D, Crumrine D, Hupe M, Arno M, Hobbs C, Cvoro A, Karagiannis P et al (2014) 3D In vitro model of a functional epidermal permeability barrier from human embryonic stem cells and induced pluripotent stem cells. Stem Cell Rep 2(5):675–689
5. Kim JS, Choi HW, Choi S, Do JT (2011) Reprogrammed pluripotent stem cells from somatic cells. Int J Stem Cells 4(1):1–8